Advertisement
Screener

SAB BIOTHERAPEUTICS, INC. (SABS) Market Cap

SAB BIOTHERAPEUTICS, INC. (SABS) Market Cap

  • 2026-09-03: Market Cap $338.47M.
  • 2026-08-03: Market Cap $344.84M.
  • 2026-06-30: Market Cap $325.62M.
  • 2026-05-06: Market Cap $290.56M.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2021-03-29 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$338.47M
2026-08-03$344.84M
2026-06-30$325.62M
2026-05-06$290.56M
2026-03-31$290.1M
2026-03-02$207.37M
2025-12-31$178.06M
2025-11-10$152.34M
2025-09-30$95.46M
2025-08-01$23.22M
2025-06-30$16.31M
2025-05-02$14.87M
2025-03-31$12.64M
2025-03-21$15.98M
2024-12-31$35.24M
2024-11-01$35.81M
2024-09-30$24.92M
2024-08-02$24M
2024-06-30$28.61M
2024-05-16$35.72M
2024-03-31$41.9M
2024-03-18$49.82M
2023-12-31$63.47M
2023-10-31$523.19M
2023-09-30$329.61M
2023-07-31$423.79M
2023-06-30$434.21M
2023-05-05$437.96M
2023-03-31$221.75M
2023-03-28$226.79M
2022-12-31$29.74M
2022-11-03$426.01M
2022-09-30$301.65M
2022-07-29$464.73M
2022-06-30$623.95M
2022-04-28$1.05B
2022-03-31$1.62B
2022-03-28$902.06M
2021-12-31$3.4B
2021-11-15$4.13B
2021-09-30$331.85M
2021-08-09$1.47B
2021-06-30$465.73M
2021-05-20$1.45B
2021-03-31$437.64M
2021-03-29$1.48B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Ocugen, Inc. (OCGN)United States$0.343B-6.34
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05